Strumento inattivo

Azioni BioMimetic Therapeutics, Inc.

Azioni

Prezzo di chiusura Nasdaq Altri mercati azionari
- ^USD	-

BioMimetic Therapeutics, Inc. : Initiates Enrollment in Augment? Chronic Tendinopathy Clinical Trial	03/01/13
BioMimetic Therapeutics, Inc. : Law Office of Brodsky & Smith, LLC Announces Investigation of BioMimetic Therapeutics, Inc.	20/11/12
BioMimetic Therapeutics, Inc. : BioMimetic Therapeutics Investor Alert: Briscoe Law Firm and Powers Taylor, LLP Investigate Sale to Wright Medical Group	20/11/12
BioMimetic Therapeutics, Inc. : Wright Medical Group, Inc. and BioMimetic Therapeutics, Inc. Enter into Agreement to Combine Businesses	19/11/12
BioMimetic Therapeutics, Inc. : Reports Third Quarter 2012 Financial Results	05/11/12

Settore

	Variaz. 1 gen.	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	+19,74%	124 Mrd
REGENERON PHARMACEUTICALS, INC.	+20,25%	114 Mrd
ARGENX SE	+21,11%	25,83 Mrd
BIONTECH SE	-23,63%	19,42 Mrd
GENMAB A/S	-18,17%	16,2 Mrd
BEIGENE, LTD.	-20,18%	15,31 Mrd
SAREPTA THERAPEUTICS, INC.	+56,08%	14,32 Mrd
NEUROCRINE BIOSCIENCES, INC.	+7,24%	14,31 Mrd
WUXI APPTEC CO., LTD.	-48,79%	14,19 Mrd